Bond.az White LogoBond.az Black Logo

Okta price target raised to $110 by Cantor

Cantor Fitzgerald raised Okta price target to $110 from $100, citing workforce growth. Stock has 17% upside. Earnings due May 28.

Harper Clark
ByHarper Clark- Senior Editor
|
0

Cantor Fitzgerald raised its price target on Okta (NASDAQ:OKTA) to $110 from $100, maintaining an Overweight rating. The stock currently trades at $93.81, implying roughly 17% upside potential.

The firm increased its 12-month price target ahead of Okta's first-quarter fiscal 2027 earnings report, due on May 28 after market close. Channel checks showed 79% of partners reporting results in line or above plan, down from 92% in the prior quarter.

Workforce identity was identified as the dominant growth driver. Cantor expects first-quarter cRPO growth in the 10-11% range. A print at 11% or above would sustain the recent stock move.

Okta for AI Agents reached general availability in April, but pipeline conversion and pricing remain unproven. Management has called this a fiscal 2028-2029 story.

The stock trades at about 4.5 times estimated fiscal 2027 sales versus peers at 8.9 times. Okta's gross profit margin of 77% and revenue growth of nearly 12% support its operational efficiency despite the valuation discount.

More News
Today / 11:04
|
827

Evercore ISI Reiterates Amphenol Outperform $180 Target

Evercore ISI reiterates Outperform rating and $180 target on Amphenol. AI revenue could exceed $9 billion by 2026.

0
Today / 11:02
|
602

Oppenheimer Cuts Deere Price Target on Brazil Weakness

Oppenheimer cut Deere's price target to $680 from $715, citing Brazil agricultural weakness and tariff impacts, while maintaining an Outperform rating.

0
Today / 09:33
|
700

Truist Cuts Zscaler Price Target to $200

Truist Securities cuts Zscaler price target to $200, maintains Buy rating. Conservative FY2027 outlook drives stock down 20%.

0
Today / 09:32
|
715

Guggenheim Reiterates Neutral on CrowdStrike Stock

Guggenheim maintains Neutral rating on CrowdStrike (CRWD) citing valuation. Read analysis on stock performance and outlook.

0
Today / 09:01
|
256

Mizuho Starts Century Therapeutics at Outperform

Mizuho initiated coverage on Century Therapeutics with an Outperform rating and $8.00 target, highlighting cell therapy for Type 1 Diabetes.

0
Today / 07:32
|
969

Barclays Upgrades GXO, Raises Price Target to $65

Barclays upgrades GXO Logistics to Overweight, raising price target to $65, citing margin improvement and US expansion.

0
Today / 06:35
|
238

JPMorgan Initiates Larimar at Overweight

JPMorgan starts Larimar Therapeutics at Overweight with $9 target. Stock at $3.47. Key developments on nomlabofusp.

0
Today / 06:02
|
267

Seaport Starts GE Aerospace Coverage with Buy

Seaport Global Securities starts GE Aerospace coverage with a buy rating and $375 price target, citing aftermarket growth potential.

0
Yesterday / 19:30
|
683

Truist Cuts Boston Properties Price Target on Rates

Truist Securities cuts Boston Properties target to $64 from $70, hold rating maintained. Higher rates and capex drive estimate reductions.

0
Yesterday / 12:35
|
248

BayCom Stock Rating Downgraded After Mgmt Changes

DA Davidson downgrades BayCom stock to Neutral after management changes. Find details on price target, dividend, and new leadership.

0
Yesterday / 12:04
|
789

CoreWeave Stock: AI Infrastructure Demand

Deutsche Bank reaffirms Buy rating on CoreWeave amid AI infrastructure demand. Key financials and market insights.

0
Yesterday / 12:03
|
656

Tenable price target raised to $29

Stephens raised Tenable price target to $29, citing platform focus and AI opportunities. Tenable One adoption and new pricing are key catalysts.

0
...
Okta price target raised to $110 by Cantor | Bond.az